|Articles|December 1, 2013
- BioPharm International-12-01-2013
- Volume 26
- Issue 12
BioPharm International, December 2013 Issue (PDF)
Click the title above to open the BioPharm International December 2013 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 12 years ago
Jobs Are Better in Biopharma, But There Is Room for Improvementabout 12 years ago
Climate Change in Outsourcingabout 12 years ago
Comparing Protein A Resins for Monoclonal Antibody Purificationabout 12 years ago
Understanding and Modeling Product and Process Variationabout 12 years ago
Opioid Regulation Challenges FDA and Manufacturersabout 12 years ago
Implementing QbD in Sterile Manufacturingabout 12 years ago
Biotechnology Innovation and Growth in Israelabout 12 years ago
Employment Outlook: Mixed ResultsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5
